Get started
Author

Abram Arnold

Observed name: Abram S. Arnold
ORCID: 0000-0001-6017-9071
Observed ORCID: 0000-0001-6017-9071
OpenAlex ID: A5029353238
Clinical Utility of Mobocertinib in the Treatment of NSCLC – Patient Selection and Reported Outcomes
2023 · Abram Arnold, Apar Kishor Ganti · OncoTargets and Therapy · 5
PDF
Outcomes following off-site remote chemotherapy administration.
2022 · Abram Arnold, Samia Asif, et al. · Journal of Clinical Oncology · 3
Outcomes following off‐site remote systemic cancer therapy administration
2024 · Abram S. Arnold, Samia Asif, et al. · Cancer · 2
Single center retrospective analysis of neoadjuvant therapy in resectable pancreatic adenocarcinoma.
2026 · Abram Arnold, Aaron Murray, et al. · Journal of Clinical Oncology
Efficacy and safety of tazemetostat in patients with refractory/relapsed follicular lymphoma or diffuse large B cell lymphoma: Systematic review and meta analysis.
2025 · Eric Wah Sanji, Juste Ongeh Niba, et al. · Journal of Clinical Oncology
Works count: 5
Citation count: 10
H-index: 2
I10-index:
Year
Topic
Type